Download Presentación de PowerPoint

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Diastolic Heart Failure
Carmen B. Gomez MD
Eugene Yevstratov MD
“The very essence of cardiovascular
medicine is recognition of early heart failure.”
Sir Thomas Lewis 1933
Introduction
Diastolic heart failure has emerged over the
last 10 years as a separate clinical entity.
Diastolic heart failure accounts for
approximately one third of all heart failure
cases, especially in an elderly population,
and its natural history, with an annual
mortality rate of 8%, is more benign than
other forms of heart failure with an annual
mortality of 19%. A need has therefore
grown to establish precise criteria for the
iagnosis of diastolic heart failure.
Requirments for Diagnostic
of the DHF
 Presence
of sighs or symptoms of
congestive heart failure
 Presence of normal or only midly
abnormal left ventricular systolic
function
 Evidence of abnormal left ventricular
relaxation(filling,diastolic
distensibility or diastolic stiffness)
Pathophysiology
Impaired
relaxation
Increase passive stiffness
Endocardial and pericardial
disordersw
Microvascular flow.Myocardial
turgor
Neurohormonal regulation
Pathophysiology
Impaired Relaxation
Epicardial
or microvascular
ischemia
Myocite hypertrophy
Cardiomyopathies
Aging
Hypothyroidism
Pathophysiology
Increase Passive Stiffness
Diffuse fibrosis
 Post-infarct scarring
 Myocyte hypertrophy
 Infiltrative (amyloidosis,
hemochromatosis, Fabry´s disease)

Pathophysiology
Endocadial, Pericardial Disorders
Fibroelastosis
 Mitral or tricuspid stenosis
 Pericardial constriction
 Pericardial tamponade

Pathophysiology
Endocadial, Pericardial Disorders
Pathophysiology
Microvascular Flow,Myocardial Turgor
Capillary compression
 Venouse engorgement

Pathophysiology
Microvascular Flow,Myocardial Turgor
Pathophysiology
Neurohormonal Regulation, Other
Upregulated renin-angiotensin
system
 Volume overload of the
contralatetal ventricle
 Extrinsic compression by tumor

Diagnosis
Increased ventricular filling pressure with
normal systolic function.
 Incresed ventricular pressure with
preserved systolic function and normal
ventricular volumes.
 Increased left atrial and pulmonary
capillary wedge pressure.
 Clinical symptoms and signs.

Clinical Signs and Symptoms







Evidence of raised left atrial pressure
Exertional dyspnoea
Orthopnoea
Gallop sounds
Lung crepitations
Pulmonary oedema
Exercise intolerance
Pathology
Evidence of Abnormal left
Ventricular Relaxation
LVdP/dt min<1100 mmHg
 IVRT<30y>92 ms, IVRT30–50y>100
ms, IVRT>50y>105 ms and/or
Ù>48 ms
 LVEDP>16 mmHg or mean
PCW>12 mmHg
 PV A Flow >35 cm . s"1
 b>0·27 and/or b*>16

Management of DHF
Reduce symptoms
 Control hypertension
 Prevent myocardial ischemia

There is no specific therapy for DHF
Management of DHF

Diuretics – provide the most symptoms relief if
fluid retentionn is a future

ACE inhibitors and β Blockers –
complement diuretics well

Central sympatholytics –
hypertensive
episodes
Nitrates – preventing ischemia
 Trimetazidine – as a metabolic support

Conclusion
Until further evidence is available from
randomized therapeutic trials, clinicians should
focus on a few general principles in the treatment
of DHF:
Reduce volume overload
Slow the heart rate
Control hypertension,
Relieve myocardial ischemia.
http://myprofile.cos.com/eugenefox
FUNDACION FAVALORO
INSTITUTO DE CARDIOLOGIA Y CIRUGIA
CARDIOVASCULAR
Carmen B. Gomez MD
Eugene Yevstratov MD
Related documents